ArticleCureus2024
Multimodal Therapeutic Exercises and Their Role in Mitigating Chemotherapy-Induced Peripheral Neuropathy: A Longitudinal Study on Patient Outcomes.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction A common side effect post chemotherapy is chemotherapy-induced peripheral neuropathy (CIPN). The purpose of this study was to investigate the effect of a multimodal exercise program compared to standard physical therapy in treating CIPN symptoms and improving daily living skills. Aim The aim of this study was to evaluate the effect of multimodal therapeutic exercises and their role in mitigating CIPN symptoms on the neuropathy score and instrumental activities of daily living. Methodology Seventy-eight participants were divided into two groups: multimodal exercise program (Group A) and standard physical therapy (Group B) who fulfilled the inclusion criteria of age 25-55 years with CIPN (grade 2 or 3). Pre- and post-assessment was done using the modified Total Neuropathy Score (mTNS) and Lawton Instrumental Activities of Daily Living Scale (L-IADL). Results A significant improvement in the mTNS was seen in Group A (14.68 ± 1.66 to 7.03 ± 1.49, p<0.0001) compared to Group B (14.98 ± 1.54 to 13.66 ± 1.34, p=0.00116). L-IADL scores also showed more improvement in Group A (7.54 to 11.23, p<0.0001) versus Group B (5.51 to 7.35, p=0.001). A statistically significant improvement was seen (p<0.0001) for both outcome measures post-intervention. Conclusion A superior efficacy was demonstrated by the multimodal exercise program demonstrated in reducing CIPN symptoms and improving functional outcomes compared to standard physical therapy. These findings suggest that comprehensive, multimodal exercise interventions may be more effective in managing CIPN and enhancing quality of life for cancer patients undergoing neurotoxic chemotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.